*Comparison of the probability of tumor improvement versus tumor non-improvement among patients on Bleomycin/Vincristine versus those on Vincristine monotherapy. In model (A), only patients with recor
TBSA = total body surface area. LOS = length of stay. Data are presented as means ± SEM, counts, or percentages. *Significant difference for control versus ketoconazole for corresponding parameter
